AGP Executive Report
Last update: 2 hours agoPublic Health Watch: A University of Minnesota study reports Minnesota teen cannabis use fell from 13% (2013) to 5% (2025), but gaps persist—American Indian/Alaska Native, LGBTQ+ and youth in poverty are about three times more likely to use than white, straight, and non-impoverished peers. Regulation & Safety: The FDA is weighing whether seven unapproved peptides should be allowed in certain compounded prescription drugs, citing past concerns about safety risks like heart toxicity and serious immune reactions. Policy & Industry: ONE HEMP backs the bipartisan Lawful Hemp Protection Act, pushing for a federal 1% THC limit, 21+ age rules, labeling standards, and a ban on synthetic/chemically modified cannabinoids. Medical Cannabis Business: Aurora’s Safari Flower earns EU-GMP certification for its Ontario facility, aiming to strengthen access to regulated international medical cannabis markets. Product Launches: Tilray Canada rolls out ZONNA fast-acting THC pouches, and Señorita becomes the official THC beverage partner of Lollapalooza with 5mg hemp-derived THC cans. Enforcement: South Africa reports 12,009 undocumented foreigners arrested in three weeks, including a case involving 379kg of cannabis worth over R7.5m. Global Drug Trends: A South America-focused report warns synthetic opioids, ketamine and “pink cocaine” are rising fast as harm reduction services lag.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
